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Abstract
Objectives
Autopsy rates worldwide have dropped significantly over the last decades and imaging-
based autopsies are increasingly used as an alternative to conventional autopsy. Our aim
was to evaluate the clinical performance and cost of minimally invasive autopsy.
Methods
This study was part of a prospective cohort study evaluating a newly implemented minimally
invasive autopsy consisting of MRI, CT, and biopsies. We calculated diagnostic yield and
clinical utility—defined as the percentage successfully answered clinical questions—of mini-
mally invasive autopsy. We performed minimally invasive autopsy in 46 deceased (30 men,
16 women; mean age 62.9±17.5, min-max: 18–91).
Results
Ninety-six major diagnoses were found with the minimally invasive autopsy of which 47/96
(49.0%) were new diagnoses. CT found 65/96 (67.7%) major diagnoses and MRI found 82/
96 (85.4%) major diagnoses. Eighty-four clinical questions were asked in all cases. Sev-
enty-one (84.5%) of these questions could be answered with minimally invasive autopsy.
CT successfully answered 34/84 (40.5%) clinical questions; in 23/84 (27.4%) without the
need for biopsies, and in 11/84 (13.0%) a biopsy was required. MRI successfully answered
60/84 (71.4%) clinical questions, in 27/84 (32.1%) without the need for biopsies, and in 33/
84 (39.8%) a biopsy was required. The mean cost of a minimally invasive autopsy was
€1296 including brain biopsies and €1087 without brain biopsies. Mean cost of CT was €187
and of MRI €284.
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Conclusions
A minimally invasive autopsy, consisting of CT, MRI and CT-guided biopsies, performs well
in answering clinical questions and detecting major diagnoses. However, the diagnostic
yield and clinical utility were quite low for postmortem CT and MRI as standalone modalities.
Introduction
Autopsy rates worldwide have dropped significantly, from rates of up to 50% in 1960s to
0–10% today. [1–3] Both in forensic and clinical medicine, the imaging autopsy is increasingly
used as adjunct or alternative to the conventional autopsy. Noninvasive autopsies use CT,
MRI, or ultrasound as stand-alone test or combinations of diagnostic tests. [4, 5] A minimally
invasive autopsy may include laparoscopy, CT-angiography (CTA) and/or image-guided tissue
biopsies. [6–19] The value of the modern imaging autopsy in the hospital setting is now under
investigation and first studies show that postmortem MRI and CTA have good performance
for establishing the cause of death and related or unrelated diagnoses. [6, 20] In this study, we
share our results of the implementation of minimally invasive autopsy procedure in our hospi-
tal over a 1-year-period. Because not much is reported yet about the clinical performance and
costs of such procedures, our aim was to evaluate diagnostic yield and clinical utility—defined
as the percentage of successfully answered clinical questions—and to calculate the cost of mini-
mally invasive autopsy—consisting of MRI, CT, and CT-guided biopsies.
Methods
Study design and patients
This prospective cohort study was performed at the Erasmus University Medical Center in
Rotterdam, the Netherlands, from September 2016 to December 2017. This study was
approved by the Erasmus MC Medical Ethical Committee (file number MEC-2011-055). Writ-
ten informed consent from relatives was acquired in all included cases. During this period
both minimally invasive, and conventional autopsy were available to the next-of-kin of all
deceased adult patients. Consent for both autopsy methods was asked by the treating physi-
cian. In difficult cases we offered the option to perform both minimally invasive autopsy and
conventional autopsy, or minimally invasive autopsy combined with a partial conventional
autopsy of a specified organ or organ system (e.g. minimally invasive autopsy combined with a
partial conventional autopsy of the heart and lungs). In these cases, the minimally invasive
autopsy was performed first, and if imaging alone did not answer all clinical questions and
give a definite cause of death, minimally invasive autopsy was followed by conventional
autopsy, or partial autopsy on the same day. The size of the cohort was determined by the
1-year inclusion period.
Minimally invasive autopsy
Preparation and transportation. The bodies were stored in a refrigerated environment
during the period between arrival in the mortuary and the start of imaging. Prior to minimally
invasive autopsy the body received general postmortem care in the mortuary. This consisted of
cleaning, photographing and removing metal and implanted medical materials in and around
the body (only if there was no clinical suspicion about their correct positioning). Next, the
body was placed in an MRI compatible body bag.
Clinical performance and costs of minimally invasive autopsy
PLOS ONE | https://doi.org/10.1371/journal.pone.0219291 July 16, 2019 2 / 19
Funding: This work was supported by Erasmus
Medical Centre Health Care Efficiency (grant 2010-
10112), Erasmus MC Vriendenfonds (grant
104117), and Stichting Coolsingel (grant 255). The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Imaging. MRI was performed on a 1.5T scanner (Discovery MR450, GE Healthcare, Mil-
waukee, Wisconsin USA), prior to CT scanning. The body was scanned in supine position and
was not moved after initial positioning was completed. MRI acquisition contained T1-weighted
and T2-weighted scans from head and torso, scanned in 5 segments of 20 cm (Table 1), supple-
mented with additional acquisitions that depended on the clinical questions (S1 Protocol). MRI
scanning time was limited to 1 hour, excluding transportation and positioning.
CT scans were acquired from head to feet (SOMATOM Definition Edge, Siemens Health-
care, Forchheim, Germany), according to a standardized protocol (Table 2).
A board-certified radiologist interpreted the CT and MRI scans directly after acquisition
was completed, compared the postmortem scans with available premortem imaging, and iden-
tified suspected pathological lesions to plan CT-guided biopsies. The radiologist was familiar
with the medical history and had access to the electronic patient record.
Biopsies. A board-certified pathologist and the treating clinician were consulted to dis-
cuss imaging findings and plan biopsy targets. CT-guided biopsies were performed with a
reusable biopsy instrument (Bard Biopsy Systems, Tempe, USA) directly after the CT scan was
completed. Biopsies (12 Gauge) were routinely taken from heart, lungs, liver, kidneys, and
spleen. Additional biopsies were taken from suspected pathology at imaging. From every
biopsy location 4–6 different needle biopsies were sampled to reduce the risk of sampling
error. Microbiology cultures and fluid for cytology were sampled upon indication. Histologic
staining (H&E) was performed according to department protocol and upon examination of
the pathologist additional pathological stains were performed on indication. If consented to,
stereoscopic brain biopsies were planned and executed using a stereoscopic navigation system
(Brainlab Kolibri, Brainlab, Munich, Germany). The radiologist performed the brain biopsies
in the mortuary directly after the CT-guided biopsies of the torso were completed.
Reporting. The radiologist made a standardized radiology report that included both
imaging findings and biopsy targets. Postmortem imaging was compared to antemortem
imaging when available. Radiologists or pathologists in different subspecialties were consulted
when organ-specific expertise was required. The pathologist evaluated the biopsies and dis-
cussed the imaging and microscopic findings with the radiologist during interdisciplinary
meetings. The pathologist integrated the radiological report in the autopsy report and both
pathologist and radiologist authorized the final minimally invasive autopsy report. Both the
Table 1. Postmortem MRI protocol.
T1 T2
Repetition time (ms) 3285 9400
Echo time (ms) 10 42
Inversion time (ms) 892 120
Echo-train-length 6 10
NSA 0.5 1.0
Flip angle (˚) 160 160
Coil Body coil Body coil
Slice width (mm) 5.0 5.0
FOV (mm) 480x288 480x288
Matrix 384x224 288x160
MRI was performed with a 1.5-T scanner (Discovery MR450; GE Medical Systems, Milwaukee, Wis). NSA = number
of signals averaged, FOV = field of view.
https://doi.org/10.1371/journal.pone.0219291.t001
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radiologist and pathologist had knowledge of the patient history and clinical questions and
these were always addressed in the final report.
The whole process of preparation, imaging, biopsies and reporting is schematically shown
in Fig 1.
Data analysis
Clinical performance
Diagnostic yield. All major diagnoses found with minimally invasive autopsy (CT, MRI,
biopsies, or partial autopsy) were registered in a clinical data file (Microsoft Excel). Major diag-
noses were defined as diagnoses related to the cause of death. For all diagnoses we registered if
the diagnosis was found with CT and/or MRI, and if a biopsy was needed. For analysis purposes
imaging confidence scores were attributed on the diagnosis level for CT and MRI separately. A
diagnosis was scored as 0 if it was found on neither CT nor MRI, a diagnosis was scored as 1 if
it was detected on CT or MRI but no likely diagnosis could be made on imaging alone and a
biopsy was needed for further elucidation, a diagnosis was scored as 2 if it was detected on imag-
ing with high likelihood of being the suspected diagnosis, but a biopsy is needed for confirma-
tion, and a score of 3 was given if a definitive diagnosis could be made based on CT or MRI and
no biopsy was required for confirmation. A Chi-squared test was used to test if there was statis-
tically significant difference in diagnostic yield between CT and MRI.
Clinical utility. We calculated the percentage of clinical questions that could be answered
by minimally invasive autopsy. To evaluate this, we registered all clinical questions from the
minimally invasive autopsy request forms provided by the treating physicians. We calculated
the percentage of successfully answered clinical questions. All analyses were performed on the
individual question level. We retrospectively evaluated if the radiologist was able to provide an
answer to the clinical question with CT or MRI, or the combination of CT and MRI, and in
how many cases a biopsy was needed to answer the question. A Chi-squared test was used to
test if there was a statistically significant difference between clinical utility of CT and MRI.
Cost calculation
We evaluated the mean cost per procedure (in Euros) of the minimally invasive autopsy from
the perspective of the hospital. We recorded all direct costs of the minimally invasive autopsy
including materials used, personnel involved, energy usage, maintenance and depreciation of
scanning equipment. Overhead costs were also included in the cost calculation and included
Table 2. Postmortem CT protocol.
Total body
protocol
Head–Neck
protocol
Rotation time (s) 1.0 1.0
Tube voltage (kV) 120 100
Tube current (eff. mAs) 400 750
Slice collimation (mm) 2 x 64 x 0.6 2 x 64 x 0.6
Pitch 0.65 0.35
Scan time (s) 69.9 24.1
Reconstruction Iterative Iterative
CT was performed with a dual-source CT scanner (SOMATOM Definition Edge; Siemens, Forchheim, Germany)
and included scans of brain, neck, torso, and lower extremities.
https://doi.org/10.1371/journal.pone.0219291.t002
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Fig 1. Logistical flow-chart of minimally invasive autopsy.
https://doi.org/10.1371/journal.pone.0219291.g001
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the cost of scanning rooms used and planning costs for the imaging procedures. Other costs
were use of the hospital’s Picture Archiving and Communication System (PACS), as well as
reporting fees. Costs of the pathology department mainly comprised personnel and overhead
costs and fees for the histological processing of biopsies. Personnel cost was estimated based
on the average wage multiplied by the average amount of time required for the specified parts
of the procedure. Cost of cytology and toxicology were not factored in the cost calculation,
because both were only performed in a small number of cases. For comparison purposes we
also calculated the costs of conventional autopsy as performed in our hospital.
Results
Recruitment
We evaluated 46 cases that underwent minimally invasive autopsy. In 16 of these cases permis-
sion was given for brain biopsies. Within the group with permission for minimally invasive
autopsy, there were 6 cases with additional permission for a partial autopsy (in 5 cases partial
autopsy of heart and lungs, in 1 case partial autopsy of an adrenal lesion that was seen prior to
death). In an additional 4 cases there was permission for a full conventional autopsy after the
minimally invasive autopsy, and in 2 of these cases there was also permission for brain autopsy.
A case inclusion diagram is shown in Fig 2.
The cohort consisted of 30/46 (65.2%) men and 16/46 (34.8%) women, mean age was 62.9
years old (SD: 17.5, min-max: 18–91). MRI acquisition time was approximately 60 minutes,
CT acquisition took 20 minutes including the multiplanar reconstructions. Torso biopsies
took between 1.5 and 2.5 hours and brain biopsies approximately 1 hour. The full procedure
time including preparation and transportation was 4 to 5 hours on average, depending on the
number and location of biopsies necessary. Per minimally invasive autopsy case, 17 different
targets were biopsied on average. Cytology samples were taken in 11 cases.
Clinical performance
Diagnostic yield. Ninety-six major diagnoses were found with the minimally invasive
autopsy: 47/96 (49.0%) were new diagnoses and in another 15/96 (15.6%) the minimally
Fig 2. Case inclusion flow-chart.
https://doi.org/10.1371/journal.pone.0219291.g002
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invasive autopsy revealed an unexpected but clinically relevant diagnosis that was not known
prior to death (e.g. new information on the size or etiology of a known malignancy).
MRI had a significantly higher diagnostic yield than CT: 82 were (85.4%) found with MRI
and 65 with CT (67.7%) (p = 0.008).
The imaging confidence scores for CT and MRI are shown in Fig 3 and case examples are
shown in Figs 4–6. The specific diagnoses per case and corresponding imaging confidence
scores are detailed in Table 3.
Clinical utility. A total of 84 clinical questions were asked in 46 minimally invasive
autopsy procedures. Seventy-one (84.5%) of these questions could be answered with minimally
invasive autopsy.
CT could answer 34/84 (40.5%) of clinical questions; in 23/84 (27.4%) without the need for
biopsies, and in 11/84 (13.0%) a biopsy was required. MRI could answer 60/84 (71.4%) of clini-
cal questions, in 27/84 (32.1%) without the need for biopsies, and in 33/84 (39.8%) a biopsy
was required. MRI had significantly higher clinical utility than CT (p<0.001).
The combination of CT and MRI could answer 65/84 (77.4%) of clinical questions, in 30/84
(35.7%) without the need for biopsies, and in 35/84 (41.7%) a biopsy was required. Six addi-
tional questions of the 84 (7.1%) were answered based on histological findings that were not
seen on imaging (i.e. biopsies taken with random sampling of organs). Table 4 shows the per-
formance of CT and MRI for clinical questions in our cohort and gives an estimate of the
hypothetical performance, based on expert opinion, of conventional autopsy for these
questions.
Costs
The mean cost of a minimally invasive autopsy was €1296 including brain biopsies and €1087
without brain biopsies. Mean cost of CT was €117 and of MRI €215. Mean cost of CT-guided
biopsies was €685. The different components of minimally invasive autopsy and their respec-
tive cost are detailed in Table 5.
The mean cost of a full conventional autopsy was €991 including brain autopsy and €740
without brain autopsy. Costs of the different components of conventional autopsy are found in
Table 6.
Discussion
This study on a minimally invasive autopsy, using MRI, CT and CT-guided biopsies, provides
insight into the diagnostic yield, clinical utility and costs of commonly used postmortem imag-
ing methods. The percentage of clinical questions answered with the complete minimally inva-
sive autopsy method (MRI, CT and biopsies combined) was very high (84.5%), but CT and
MRI as standalone modalities left many questions unanswered. Diagnostic yield of MRI was
higher than CT: 85% of diagnoses were found with MRI versus 68% with CT. Most diagnoses
required biopsies for confirmation; diagnostic yield of CT and MRI without biopsies was low.
The mean cost of a full minimally invasive autopsy was €1296, and by far the most expensive
part of the procedure were the CT-guided biopsies. For comparison, a full conventional
autopsy (including brain autopsy) in our hospital had a mean cost of €991. In terms of time; a
minimally invasive autopsy took approximately 4 to 5 hours, depending on the complexity of
the case and the required biopsies. A conventional autopsy on average takes between 2.5 and 4
hours.
In a previously published study, we compared the performance for finding the immediate
cause of death and related major diagnoses of minimally invasive autopsy—consisting of CT,
MRI and CT-guided needle biopsies–versus a conventional autopsy. Minimally invasive
Clinical performance and costs of minimally invasive autopsy
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Fig 3. Diagnostic yield of postmortem CT and MRI. Red–Imaging confidence score 0: diagnosis not detected; Orange–
score 1: diagnosis detected on imaging, but unclear; biopsy required; Yellow–score 2: diagnosis seen on imaging and
likely, biopsy required for confirmation; Green—score 3: diagnosis certain, no biopsy required.
https://doi.org/10.1371/journal.pone.0219291.g003
Clinical performance and costs of minimally invasive autopsy
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autopsy and conventional autopsy performed equally well in finding the cause of death,
whereas minimally invasive autopsy found a greater number of major diagnoses than conven-
tional autopsy. Furthermore, both minimally invasive autopsy and conventional autopsy
found unexpected postmortem findings that were considered relevant new information for the
treating physicians: 124/288 (43.1%) of the major diagnoses and 17/99 (17%) of the causes of
death were not clinically suspected before death. [21]
Earlier studies on the diagnostic performance of non-invasive and minimally invasive
autopsies found that the performance of contrast enhanced imaging methods was better than
that of non-contrast enhanced imaging. Furthermore, methods combining radiology with tis-
sue-biopsies had a higher diagnostic performance than imaging alone. [11, 17]
In this study we evaluated the clinical utility of minimally invasive autopsy, defined as the
percentage of successfully answered clinical questions by this new autopsy method. In our
experience this outcome measure is highly valued by clinicians when they request an autopsy,
and often this is considered equally as important as finding the cause of death. Our results
show that the diagnostic yield and clinical utility of CT and MRI without biopsy is low. This
finding is in line with diagnostic studies on imaging-based autopsies: methods combining
imaging with biopsy showed highest sensitivity and specificity. [11, 21] Nevertheless CT and
MRI both have strengths and weaknesses. CT is noninvasive, relatively cheap, and widely avail-
able. Additionally, CT performs well at visualizing (abnormal) air collections and skeletal
abnormalities, such as fractures and bone lesions. A clinical study found that postmortem CT
is more accurate in establishing the cause of death than the clinician. [22] However, our results
indicate a low performance of CT as standalone test, because unenhanced CT lacks the high
soft-tissue contrast necessary to diagnose some common causes of death, such as acute myo-
cardial infarction. [23] Studies on postmortem CTA show that it has a higher sensitivity, but
CTA is logistically challenging to perform in a clinical setting and is not purely non-invasive.
[24] MRI has excellent soft-tissue contrast, but it is more expensive and generally has longer
scanning times and lower availability than unenhanced CT.
Because of its good soft-tissue discrimination, MRI was able to detect more major diagnoses
in our study cohort. Cardiac diagnoses in particular were better diagnosed with MRI; acute
myocardial infarctions were not seen at all with unenhanced CT-imaging, but MRI detected
10 out of 12 myocardial infarctions. Chronic myocardial infarction can sometimes be detected
with CT in a late stage where wall thinning is present, in our cohort this was seen in 1 case.
MRI also performed much better than CT in detecting chronic myocardial infarctions: chronic
infarctions were detected with MRI in 4 out of 5 cases, and with CT in only 1 out of 5 cases.
[25] Pneumonia, another common cause of death, was detected both with MRI and CT, but
postmortem artefacts in the lungs such as internal livores can mask or mimic pathologic pro-
cesses and therefore biopsies of lung abnormalities are always recommended. [26]
A closer look at the performance for answering clinical questions of CT and MRI (Table 4)
shows that CT and MRI can answer most questions, but biopsies are still necessary in the
majority of questions. Intestinal ischemia and perforation, as well as organ transplant rejection
and graft-versus-host disease are difficult to diagnose on imaging. Also, finding the etiology of
cardiac arrythmia’s is almost impossible with CT and MRI. For these diagnoses it is recom-
mended to perform a conventional autopsy when consent can be obtained. Minimally invasive
Fig 4. Acute myocardial infarction. 77-year-old woman with a history of hypertension and cerebral ischemia. She was resuscitated unsuccessfully
after she was found gasping and unresponsive in bed. Postmortem MRI found T2 hypointensity in the septal, anterior and lateral myocardium (A,
D, E: arrows) indicative of acute myocardial infarction in the area supplied by the left anterior descending (LAD) artery. CT-guided biopsies (B and
C) from the myocardium were taken and histology showed contraction band necrosis (arrows) confirming acute myocardial infarction (F).
https://doi.org/10.1371/journal.pone.0219291.g004
Clinical performance and costs of minimally invasive autopsy
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autopsy outperforms the conventional autopsy in cases where a full-body assessment is
required, e.g. the status or growth of systemic diseases or oncological processes. All clinical
questions regarding skeletal lesions or pathology involving air can be answered with postmor-
tem imaging (sometimes combined with biopsies) and in these cases we recommend either a
Fig 5. Oncologic cases. A and B: 45-year-old woman with metastasized melanoma. Postmortem T1w MRI shows extensive metastases in brain (A), liver (circle) and
spleen (arrows) (B). Tissue was sampled for histologic examination and genetic testing. C through G: 87-year-old man with a known aneurysm of the abdominal aorta,
for which he underwent endovascular aortic repair (C: circle). The clinician wanted to exclude aortic rupture or acute myocardial infarction. Minimally invasive
autopsy found prostate cancer (E: arrow) with multiple osseous metastases (D and E: arrowheads, F: arrow, G: circle) as unexpected findings. Focal signal abnormalities
in the myocardium and histology confirmed acute myocardial infarction as the cause of death (not shown in this image).
https://doi.org/10.1371/journal.pone.0219291.g005
Fig 6. Rib fractures with soft-tissue hematoma. 89-year-old woman who underwent an elective coronary angiography for mitral valve insufficiency and complaints of
angina. During the procedure she developed cardiac arrest and required cardiopulmonary resuscitation. She was transported to the intensive care, where she showed
symptoms of hypovolemic shock and she died shortly afterwards. Postmortem CT showed multiple rib fractures (A and B: arrows) and on postmortem MRI a large soft-
tissue hematoma was seen in the left flank (C: ellipse).
https://doi.org/10.1371/journal.pone.0219291.g006
Clinical performance and costs of minimally invasive autopsy
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Table 3. Case table.
Diagn. No. Diagnosis Organ CT confidence MRI confidence
1 1 Brain herniation Brain 3 3
2 Acute myocardial infarction Heart 0 2
2 1 Chronic myocardial infarction Heart 0 2
2 Acute myocardial infarction Heart 0 2
3 Pulmonary sequester Lung 2 2
3 1 Acute myocardial infarction Heart 0 2
2 Aspiration Lung 2 2
4 1 Brain hemorrhage Brain 3 3
2 Adrenal hemorrhage Adrenal gland 2 2
5 1 Lymphoma Lung 3 3
2 Aspiration Lung 1 1
3 Cellular rejection heart transplant Heart 0 0
6 1 Chronic myocardial infarction Heart 0 0
2 Acute myocardial infarction Heart 0 0
3 Brain microbleeds Brain 0 3
4 Brain hemorrhage Brain 2 2
5 Systemic infection Brain 0 0
7 1 Encephalitis Brain 0 0
2 Systemic metastases Lung 2 2
3 Lung tumor Lung 0 0
8 1 Gastrointestinal tract leakage Intestines 2 2
2 Pneumonia Lung 2 2
9 1 Myocardial hypertrophy Heart 2 2
2 Pulmonary edema Lung 1 1
3 Encephalitis Brain 0 0
10 1 Pulmonary embolism Lung 1 3
11 1 Pneumonia Lung 2 2
2 Kidney abscess Kidney 2 2
12 1 No major diagnosis found - - -
13 1 Chronic myocardial infarction Heart 2 3
2 Pulmonary edema Lung 2 2
14 1 Pneumonia Lung 2 2
2 Myocardial hypertrophy Heart 2 2
3 Pneumothorax with hematothorax Lung 3 3
15 1 Acute myocardial infarction Heart 0 2
2 Pulmonary edema Lung 2 2
16 1 Systemic metastases Bone 2 2
2 Acute myocardial infarction Heart 0 2
3 Prostate cancer Prostate 2 2
17 1 Systemic metastases Systemic 3 3
18 1 Brain hemorrhage Brain 3 3
2 Pneumothorax Lung 3 3
3 Pneumonia Lung 2 2
4 Muscle dystrophy Muscle 3 3
19 1 Rupture of abdominal aneurysm Vascular 3 3
20 1 Acute myocardial infarction Heart 0 2
21 1 Gastrointestinal tract bleeding Intestines 2 2
(Continued)
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Table 3. (Continued)
Diagn. No. Diagnosis Organ CT confidence MRI confidence
22 1 Cardiomyopathy Heart 2 2
2 Pneumonia Lung 2 2
3 Acute myocardial infarction Heart 0 2
23 1 Systemic iron overload Systemic 0 3
2 Gastrointestinal tract infection Intestines 0 2
24 1 Acute myocardial infarction Heart 0 2
25 1 Ischemia Intestines 2 2
2 Cardiomyopathy Heart 2 2
26 1 Heart failure Heart 2 2
2 Focal liver steatosis Liver 2 2
27 1 Aspergillus infection Lung 2 2
2 Graft-versus-host-disease Systemic 0 0
28 1 Lung tumor Lung 3 3
2 Systemic metastases Liver 2 2
3 Aspiration Lung 1 1
29 1 Acute myocardial infarction Heart 0 2
30 1 Systemic metastases Systemic 3 3
31 1 Pneumonia Lung 2 2
2 Lymphoma Systemic 3 3
32 1 Aspiration Lung 2 2
2 Acute pancreatitis Pancreas 2 2
33 1 Hematothorax Lung 3 3
2 Pneumothorax Lung 3 3
3 Rib fractures Skeleton 3 2
4 Pulmonary hypertension Lung 2 2
5 Spondylodiscitis Skeleton 2 2
34 1 Liver cirrhosis Liver 3 3
2 Acute tubular necrosis Kidney 0 0
35 1 Acute myocardial infarction Heart 0 0
2 Pancreatic carcinoma Pancreas 2 2
36 1 Acute myocardial infarction Heart 0 2
37 1 Pulmonary embolism Lung 1 3
2 Chronic myocardial infarction Heart 0 1
38 1 Intestinal wall thickening (inflammation) Intestines 1 1
39 1 Rupture of abdominal aneurysm Vascular 3 3
2 Breast cancer Breast 2 2
40 1 Acute myeloid lymphoma Systemic 0 2
2 Leukostasis Lung 2 2
3 Systemic infection Systemic 0 0
41 1 Pulmonary fibrosis Lung 0 0
2 Hematothorax Lung 3 3
3 Acute pneumonia Lung 0 0
42 1 Hematothorax Lung 3 3
43 1 Chronic myocardial infarction Heart 0 2
44 1 Retroperitoneal hematoma Soft tissue 3 3
2 Thoracic wall hematoma Soft tissue 3 3
45 1 Aspiration Lung 2 2
(Continued)
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minimally invasive autopsy, or otherwise combining a conventional autopsy with postmortem
CT. Furthermore the location of implanted devices is more reliably assessed on imaging,
because the position can be seen in-situ, whereas with conventional autopsy artificial move-
ment can occur during the opening of the body or removal of organs.
For our minimally invasive autopsy method we opted for a combination of CT, MRI and
CT-guided biopsies, because it combines the soft-tissue contrast of MRI, to screen the brain
and torso for soft-tissue abnormalities that can then be targeted with CT-guided biopsies. We
designed multiple different MRI protocols for different clinical scenarios. This allowed us to
scan with a higher resolution in the region of interest and use specific MRI-sequences when a
particular question demanded it, without increasing MRI scanning time to more than 1 hour:
e.g. when cerebral microhemorrhages were suspected a susceptibility-weighted MRI sequence
would be made of the brain, and when a young adult died suddenly and sudden-cardiac death
was suspected a high-resolution cardio-thoracic MRI would be performed.
Other studies have suggested that using postmortem MRI as a screening tool prior to con-
ventional autopsy in selected cases may lead to a cost reduction; in this case postmortem MRI
is performed first and is only followed by conventional autopsy if the MRI does not give a
Table 3. (Continued)
Diagn. No. Diagnosis Organ CT confidence MRI confidence
46 1 Ileus Intestines 2 2
2 Intestinal ischemia Intestines 2 2
3 Acute tubular necrosis Kidney 0 0
https://doi.org/10.1371/journal.pone.0219291.t003
Table 4. Clinical utility of postmortem CT and postmortem MRI for specific clinical questions.
Clinical question n CT
performance
MRI
performance
Biopsy required Hypothetical performance of conventional autopsy
Brain hemorrhage 3 Good Good No Good
Brain ischemia 4 Fair Good Yes Good
Meningitis 1 Poor Poor Yes Good
Myocardial infarction 13 Poor Good Yes Good
Cardiomyopathies 2 Poor Fair Yes Good
Coronary artery disease 1 Fair Poor No Good
Cardiac arrythmia 2 Poor Poor No Fair
Pulmonary embolism 6 Poor Fair Yes Good
Pneumonia 3 Fair Fair Yes Good
Pulmonary hemorrhage / Hemothorax 3 Fair Fair No Good
Rupture of abdominal aortic aneurysm 2 Good Good No Good
Intestinal perforation 1 Fair Fair No Good
Intestinal ischemia 2 Fair Fair Yes Good
Liver cirrhosis 2 Fair Good Yes Good
Implanted organ rejection / graft-versus-host disease 2 Poor Poor Yes Good
Status of (oncological) disease 4 Good Good No Fair
Position of implanted devices 3 Good Good No Fair
Infection focus 4 Fair Fair Yes Fair
CT and MRI performance were based on expert opinion of the postmortem radiologist (ACW). Hypothetical performance of conventional autopsy was based on expert
opinion of the pathologist (JWO).
https://doi.org/10.1371/journal.pone.0219291.t004
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definitive cause of death. [27] In a similar fashion we could perform a slimmed down version
of the minimally invasive autopsy on a case-per-case basis depending on the clinical questions.
For specific questions it may be possible to omit either CT or MRI and take only biopsies of
organs or tissues of clinical importance. The risk of missing important diagnoses needs to be
considered though; in our cohort 14/96 (14.6%) of diagnoses were not seen on imaging, and
would have been missed if no random sampling of all organs was performed. The sampling
success rate in our validation study was very high (>95%), because we sampled at least 4 nee-
dle biopsies per target location.
Table 6. Costs of conventional autopsy.
Postmortem care External inspection Dissection Microscopy Brain autopsy Reporting
Personnel Mortuary personnel Pathology resident Mortuary personnel Pathology resident Laboratory assistant Pathology resident
Pathologist Pathology resident Pathologist Mortuary personnel Pathologist
Mortuary personnel Pathologist Mortuary personnel
Materials Protective clothing Protective clothing Protective clothing Protective clothing Protective clothing -
Other materials Cleaning materials Other materials Cleaning materials
Other materials Other materials
Equipment - - Autopsy table Autopsy table Autopsy table -
Other costs Overhead Overhead Overhead Overhead Overhead Overhead
Histology processing Histology processing
Cost (€) 50 15 142 419 251 114
https://doi.org/10.1371/journal.pone.0219291.t006
Table 5. Costs of minimally invasive autopsy.
Postmortem care & external inspection MRI CT CT-guided biopsies Brain biopsies
Personnel Mortuary personnel Students Students Students Radiologist
Pathology resident Radiographer Radiographer Radiographer Mortuary personnel
Pathologist Radiologist Radiologist Radiologist
Pathologist
Mean cost (€) 15 109 67 240 115
Materials MRI compatible body bag Cleaning materials Cleaning materials Protective clothing Cleaning materials
Protective clothing Protective clothing Protective clothing Cleaning materials Protective clothing
Other materials Biopsy gun + needle Drill
Other materials
Mean cost (€) 55 3 3 40 3
Equipment - Scanner depreciation Scanner depreciation Scanner depreciation Brainlab navigation
Power usage Power usage Power usage Maintenance
Maintenance Maintenance Maintenance Neurosurgical skull clamp
Mean cost (€) 40 16 23 15
Other costs - Overhead Overhead Overhead Overhead
Reporting Reporting Reporting Reporting
PACS PACS PACS Histology processing
Histology processing
Mean cost (€) 63 31 382 76
Total mean cost (€) 70 215 117 685 209
PACS = picture archiving and communication system.
https://doi.org/10.1371/journal.pone.0219291.t005
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Future research should focus on different imaging strategies for various clinical circum-
stances in which patients die. The cost that a hospital is willing to pay and the measure of inva-
siveness the next-of-kin are willing to accept are important factors when deciding how to
design a postmortem imaging service. These considerations can be different depending on the
setting. For example, an intensive care doctor might be more interested in knowing the cause
of death and may be less interested in diagnoses already known or unrelated to death. In con-
trast, a clinical oncologist is more eager to know the exact tumor type in patients who were
unresponsive to treatment, warranting a more invasive technique.
Our study has several limitations. Our study includes a minimally invasive autopsy that
combines CT, MRI and biopsies. Alternative procedures, such as postmortem CTA, MRA,
and ultrasound were not part of our imaging protocol. The addition of CTA could greatly
increase the clinical performance of minimally invasive autopsy for coronary heart disease.
Our cohort was relatively small, therefore we made no attempt to aggregate diagnoses per
organ system. The costs of minimally invasive autopsy were calculated based on direct mate-
rial, personnel and overhead cost. We did not take into account that the overall cost per indi-
vidual procedure tends to increase when fewer procedures in total are performed, as overhead
costs and wages for personnel are shared between the total amount of procedures. [20] Finally,
the population that we scanned is dependent on country and setting; we investigated the per-
formance and costs in an academic hospital in the Netherlands. More studies are necessary to
evaluate performance and costs in different settings and countries.
Conclusions
A minimally invasive autopsy, consisting of CT, MRI and CT-guided biopsies, performs well
in answering clinical questions and detecting major diagnoses. However, the diagnostic yield
and clinical utility were quite low for postmortem CT and MRI as standalone modalities.
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